Article
FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression
30 Aug 2021
Abstract excerpt
Previous studies in our lab suggest that nitrogen permease regulator 2-like (NPRL2) upregulation in prostate cancer is associated with malignant behavior and poor prognosis. However, the underlying mechanisms of NPRL2 dysregulation remain poorly understood. This study aimed to explore the transcription factors (TFs) contributing to NPRL2 dysregulation in prostate cancer. Potential TFs were identified using...
Topics
Join the communities discussing this publication.
